ODI — Odi Pharma AB (publ) Balance Sheet
0.000.00%
- SEK30.06m
- SEK26.67m
- SEK32.92m
Annual balance sheet for Odi Pharma AB (publ), fiscal year end - June 30th, SEK millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Preliminary |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7.37 | 6.49 | 2.64 | 1.48 | 3.39 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.09 | 0.813 | 8.98 | 1.49 | 1.04 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 10.5 | 8.18 | 12.2 | 3.61 | 5.29 |
| Net Property, Plant And Equipment | 0.012 | 0.009 | 0.006 | 0.004 | 0.011 |
| Other Long Term Assets | |||||
| Total Assets | 10.5 | 8.19 | 12.2 | 4.61 | 5.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.24 | 5.61 | 10.2 | 4.19 | 2.93 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.24 | 5.61 | 10.2 | 4.19 | 2.93 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.26 | 2.57 | 2 | 0.425 | 2.38 |
| Total Liabilities & Shareholders' Equity | 10.5 | 8.19 | 12.2 | 4.61 | 5.3 |
| Total Common Shares Outstanding |